Prevention is key. Cancer incidence rates among women aged 50 to 64 have surpassed those of men.
The American Cancer Society (ACS) 2025 Annual Report provides an in-depth overview of the current cancer situation in the United States. It highlights promising trends, concerning developments, and underscores the critical importance of prevention and early detection in the fight against this disease.
One of the most striking findings in the report is the increase in cancer cases among women and young adults. For the first time, cancer incidence rates among women aged 50 to 64 have surpassed the cases in men.
Rates for women under 50 are now 82% higher than male. This is especially true for lung cancer, which has become more common among women under 65.
Despite the rising incidence, there is a bright spot: cancer death rates continue to decline. Between 1991 and 2022, cancer death rates fell by 34%, avoiding approximately 4.5 million deaths. This progress is attributed to a reduction in smoking, as well as advances in treatment and early diagnosis.
The report also highlights persistent challenges and inequities. Pancreatic cancer remains a significant concern, with rising incidence and mortality rates. Additionally, racial disparities in cancer mortality rates persist, with Native American and African-American showing higher rates than whites.
The ACS emphasizes the crucial role of prevention in reducing cancer incidence and mortality. Lifestyle changes, such as quitting smoking, reducing alcohol consumption, maintaining a healthy weight, and engaging in regular physical activity, can significantly reduce the risk of developing cancer. Early detection through regular screening is also critical to improving survival rates.
The ACS 2025 report highlights the importance of continued vigilance in the fight against cancer. While significant progress has been made, the increase in cases among women and young adults, combined with persistent inequities, demonstrates the need for continued efforts in prevention, early detection, and equitable access to care. Working together, we can aspire to a future where cancer is no longer a leading cause of death.
Professor Antonio Giordano, M.D., Ph.D., is the creator and head of the Sbarro Health Research Organization, located at Temple University's College of Science and Technology in Philadelphia. Stay connected with him through his various social media platforms, including Facebook, LinkedIn, Twitter, and Instagram, to receive the latest updates.
Comments